Zhejiang Medicine Yönetim

Yönetim kriter kontrolleri 3/4

Zhejiang Medicine CEO'su Chun Lei Lu, Jun2018 tarihinde atandı, in görev süresi 6.42 yıldır. şirketin hisselerinin 0.035% doğrudan sahiptir ve bu hisselerin değeri CN¥ 5.39M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.4 yıl ve 3.4 yıldır.

Anahtar bilgiler

Chun Lei Lu

İcra Kurulu Başkanı

CN¥2.8m

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	6.4yrs
CEO sahipliği	0.04%
Yönetim ortalama görev süresi	3.4yrs
Yönetim Kurulu ortalama görev süresi	3.4yrs

Son yönetim güncellemeleri

Recent updates

CEO

Chun Lei Lu (57 yo)

6.4yrs

Görev süresi

CN¥2,844,200

Tazminat

Mr. Chun Lei Lu is President and Director of Zhejiang Medicine Co., Ltd. since June 15, 2018. He serves as Vice Chairman of Zhejiang Medicine Co., Ltd.since June 16, 2021. Mr. Lu was Executive Vice Presid...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Chun Lei Lu	President & Vice Chairman	6.4yrs	CN¥2.84m	0.035% CN¥ 5.4m
Hongwei Wang	Executive Vice President	6.4yrs	CN¥2.61m	0.019% CN¥ 3.0m
Huan Ming Yu	Vice President	9.4yrs	CN¥2.05m	0.042% CN¥ 6.3m
Jianhong Ping	Vice President	3.4yrs	CN¥1.90m	0.0052% CN¥ 793.1k
Yongbin An	Senior Manager	3.4yrs	CN¥2.24m	Veri yok
Liping Liang	Senior Manager	3.4yrs	CN¥1.97m	0.0078% CN¥ 1.2m
Xiaoping Wang	Senior Manager	3.4yrs	CN¥2.10m	0.0052% CN¥ 793.1k
Nan Xing Li	Vice Chairman & Vice President	6.4yrs	CN¥2.86m	0.12% CN¥ 17.7m
Qirong Li	CFO & Financial Director	3.4yrs	CN¥1.22m	0.0052% CN¥ 793.1k
Guangshan Guo	Accounting Supervisor	no data	Veri yok	Veri yok
Minzhi Shao	Board Secretary	1.2yrs	Veri yok	Veri yok
Jin Lin Zhu	Vice President	9.4yrs	CN¥1.82m	0.036% CN¥ 5.6m

3.4yrs

Ortalama Görev Süresi

50yo

Ortalama Yaş

Deneyimli Yönetim: 600216 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.4 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Chun Lei Lu	President & Vice Chairman	12.4yrs	CN¥2.84m	0.035% CN¥ 5.4m
Nan Xing Li	Vice Chairman & Vice President	6.4yrs	CN¥2.86m	0.12% CN¥ 17.7m
Chun Bo Li	Chairman of the Board	21.4yrs	CN¥3.46m	0.0097% CN¥ 1.5m
Naiwei Chen	Independent Director	6.4yrs	CN¥120.00k	Veri yok
Yizheng Qiu	Independent Director	3.4yrs	CN¥120.00k	Veri yok
Zhenhua Chu	Director	3.4yrs	CN¥1.86m	0.0078% CN¥ 1.2m
Yuqing Yu	Director	3.4yrs	CN¥1.85m	0.0052% CN¥ 793.1k
Qing Xia	Independent Director	3.4yrs	CN¥120.00k	Veri yok
Xiaoming Wu	Independent Director	2.9yrs	CN¥120.00k	Veri yok
Zhong Liu	Vice Chairman	1.4yrs	Veri yok	Veri yok
Yiyuan Wu	Chief Supervisor	1.4yrs	Veri yok	Veri yok
Hongyu Cang	Director	1.4yrs	Veri yok	Veri yok

3.4yrs

Ortalama Görev Süresi

48.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 600216 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.4 yıldır).

Zhejiang Medicine Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Zhejiang Medicine Co., Ltd., Annual General Meeting, Jun 18, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.55 (vs CN¥0.029 in 3Q 2023)

Investor sentiment improves as stock rises 20%

Zhejiang Medicine Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released: EPS: CN¥0.23 (vs CN¥0.16 in 2Q 2023)

New minor risk - Share price stability

Investor sentiment improves as stock rises 19%

Dividend reduced to CN¥0.15

Zhejiang Medicine Co., Ltd. to Report First Half, 2024 Results on Aug 23, 2024

Zhejiang Medicine Co., Ltd., Annual General Meeting, Jun 18, 2024

First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.12 in 1Q 2023)

Zhejiang Medicine Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Investor sentiment improves as stock rises 18%

Zhejiang Medicine Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.029 (vs CN¥0.10 in 3Q 2022)

Zhejiang Medicine Co., Ltd. to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.14 in 2Q 2022)

Zhejiang Medicine Co., Ltd. to Report First Half, 2023 Results on Aug 24, 2023

First quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.27 in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.25 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.25 in 2Q 2021)

Less than half of directors are independent

Third quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.30 in 2Q 2020)

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS CN¥0.75 (vs CN¥0.36 in FY 2019)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥15.25

New 90-day low: CN¥12.75

New 90-day low: CN¥13.19

Third quarter earnings released

Third quarter earnings released

New 90-day low: CN¥14.55

Zhejiang Medicine Co., Ltd. to Report Q3, 2020 Results on Oct 23, 2020

New 90-day low: CN¥15.44

New 90-day low - CN¥16.73

First half earnings released

Earnings released

Zhejiang Medicine Co., Ltd. to Report First Half, 2020 Results on Aug 26, 2020

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş